So, What's This Exactly? | GenomeWeb

Custom-built antibodies don't always work the way they are supposed to and this can affect the results that researchers get in their experiments, NPR reports.

For instance, it notes that a multi-million dollar endeavor to develop a treatment for melanoma was disrupted after a researcher discovered that the antibodies being used were not dependable.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.